NCT06344416: An ongoing trial by Dosentrx Ltd.
This trial is ongoing. It must report results 3 months, 3 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06344416 |
|---|---|
| Title | Study of Ribociclib (Ribo) Treatment Adherence Clinical Study Protocol |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 30, 2024 |
| Completion date | March 30, 2025 |
| Required reporting date | March 30, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |